Barclays’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Barclays’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-47,438	Closed	-$1.94M	–	7370
2015 Q2	$1.94M	Sell	47,438 -2,030	-4%	-$72.8K	﹤0.01%	2241
2015 Q1	$1.73M	Sell	49,468 -13,760	-22%	-$466K	﹤0.01%	2454
2014 Q4	$2.02M	Sell	63,228 -18,758	-23%	-$543K	﹤0.01%	2528
2014 Q3	$2.29M	Buy	81,986 +33,438	+69%	+$1.02M	﹤0.01%	2537
2014 Q2	$1.46M	Buy	48,548 +1,741	+4%	+$48.1K	﹤0.01%	2946
2014 Q1	$1.26M	Buy	46,807 +34,383	+277%	+$900K	﹤0.01%	2987
2013 Q4	$311K	Sell	12,424 -318	-2%	-$9.8K	﹤0.01%	4561
2013 Q3	$369K	Sell	12,742 -8,442	-40%	-$235K	﹤0.01%	4436
2013 Q2	$609K	Buy	+21,184	New	+$584K	﹤0.01%	3979

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Barclays's BRLI Position: Q3 2015 in Review

Barclays sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 47,438 shares — an estimated $1.94M sold.

Barclays first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $2.29M in Q3 2014. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Barclays reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Barclays sold 47,438 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.94M.
Barclays first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
Barclays's BIO-REFERENCE LABS INC-NEW- position peaked at $2.29M in Q3 2014.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.